CNMD250117C50000
- 0.00
- 0.000.00%
ConMed Newsroom
Top SA Quant-rated Medical Devices Stocks as Technicals Look Strong
Stifel Maintains ConMed(CNMD.US) With Buy Rating, Maintains Target Price $72
Conmed Highlights Growth Strategy at Healthcare Conference
CONMED Corporation to Announce Fourth Quarter 2024 Financial Results on February 5, 2025
BofA Securities Maintains ConMed(CNMD.US) With Hold Rating
The Three-year Underlying Earnings Growth at CONMED (NYSE:CNMD) Is Promising, but the Shareholders Are Still in the Red Over That Time
CONMED Corporation to Present at the J.P. Morgan Healthcare Conference
Analysts Offer Insights on Healthcare Companies: Crinetics Pharmaceuticals (CRNX), Conmed (CNMD) and Veeva Systems (VEEV)
Is It Too Late To Consider Buying CONMED Corporation (NYSE:CNMD)?
ConMed To Go Ex-Dividend On December 20th, 2024 With 0.2 USD Dividend Per Share
CONMED Keeps Quarterly Dividend at $0.20 Per Share; Payable Jan. 3 to Shareholders of Record on Dec. 20
Conmed Declares Dividend of 20c >CNMD
Press Release: CONMED Corporation Announces Quarterly Cash Dividend
Is CONMED Corporation's (NYSE:CNMD) 14% ROE Strong Compared To Its Industry?
Conmed's BioBrace Implant Shows Promise but Awaits Crucial Trial Results Amid Financial Considerations
Why Conmed (CNMD) Is a Top Growth Stock for the Long-Term
Top 3 Health Care Stocks That May Dip This Month
CONMED (NYSE:CNMD) Seems To Use Debt Quite Sensibly
CONMED Corporation to Participate in a Fireside Chat at the Piper Sandler Healthcare Conference
We Think That There Are Issues Underlying CONMED's (NYSE:CNMD) Earnings